ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD • FR0000035081

21.02 EUR
-0.52 (-2.41%)
Last: Feb 12, 2026, 05:29 PM
Fundamental Rating

3

Taking everything into account, ICAD scores 3 out of 10 in our fundamental rating. ICAD was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and financial health of ICAD have multiple concerns. ICAD has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ICAD had positive earnings in the past year.
  • ICAD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
  • In the past 5 years ICAD always reported a positive cash flow from operatings.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • ICAD has a worse Return On Assets (-1.84%) than 80.95% of its industry peers.
  • ICAD's Return On Equity of -4.78% is on the low side compared to the rest of the industry. ICAD is outperformed by 80.95% of its industry peers.
  • The Return On Invested Capital of ICAD (2.76%) is worse than 71.43% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.45%.
  • The last Return On Invested Capital (2.76%) for ICAD is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • Looking at the Operating Margin, with a value of 19.60%, ICAD is doing worse than 78.57% of the companies in the same industry.
  • ICAD's Operating Margin has declined in the last couple of years.
  • The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICAD is destroying value.
  • Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
  • The number of shares outstanding for ICAD has been increased compared to 5 years ago.
  • Compared to 1 year ago, ICAD has a worse debt to assets ratio.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.64, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
  • ICAD's Altman-Z score of 0.64 is on the low side compared to the rest of the industry. ICAD is outperformed by 61.90% of its industry peers.
  • ICAD has a debt to FCF ratio of 45.31. This is a negative value and a sign of low solvency as ICAD would need 45.31 years to pay back of all of its debts.
  • ICAD has a worse Debt to FCF ratio (45.31) than 76.19% of its industry peers.
  • A Debt/Equity ratio of 0.97 indicates that ICAD is somewhat dependend on debt financing.
  • ICAD's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. ICAD is outperformed by 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Altman-Z 0.64
ROIC/WACC0.95
WACC2.9%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • ICAD has a Current Ratio of 1.06. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ICAD has a better Current ratio (1.06) than 78.57% of its industry peers.
  • ICAD has a Quick Ratio of 1.06. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ICAD (0.81) is better than 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

  • The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
  • ICAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.69% yearly.
  • Looking at the last year, ICAD shows a very negative growth in Revenue. The Revenue has decreased by -13.82% in the last year.
  • The Revenue has been growing slightly by 0.64% on average over the past years.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.39% on average over the next years.
  • Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -2.44% on average per year.
EPS Next Y10.09%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
EPS Next 5YN/A
Revenue Next Year-6.32%
Revenue Next 2Y-3.05%
Revenue Next 3Y-2.44%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.05, the valuation of ICAD can be described as very cheap.
  • Based on the Price/Earnings ratio, ICAD is valued cheaper than 92.86% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ICAD to the average of the S&P500 Index (28.18), we can say ICAD is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 6.81, the valuation of ICAD can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 97.62% of the companies listed in the same industry.
  • ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 7.05
Fwd PE 6.81
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ICAD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICAD is cheaper than 92.86% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ICAD.
Industry RankSector Rank
P/FCF 15.53
EV/EBITDA 10.59
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ICAD's earnings are expected to decrease with -3.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%

4

5. Dividend

5.1 Amount

  • ICAD has a Yearly Dividend Yield of 5.35%, which is a nice return.
  • ICAD's Dividend Yield is comparable with the industry average which is at 5.29.
  • Compared to an average S&P500 Dividend Yield of 1.80, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

  • The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-186.23%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (2/12/2026, 5:29:48 PM)

21.02

-0.52 (-2.41%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22
Earnings (Next)02-17
Inst Owners73.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.60B
Revenue(TTM)1.50B
Net Income(TTM)-186.70M
Analysts51.82
Price Target22.17 (5.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-186.23%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.86%
PT rev (3m)-10.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.21%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 7.05
Fwd PE 6.81
P/S 1.07
P/FCF 15.53
P/OCF 4.88
P/B 0.41
P/tB 0.41
EV/EBITDA 10.59
EPS(TTM)2.98
EY14.18%
EPS(NY)3.09
Fwd EY14.69%
FCF(TTM)1.35
FCFY6.44%
OCF(TTM)4.3
OCFY20.48%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.7
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.88%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Debt/EBITDA 9.41
Cap/Depr 210.38%
Cap/Sales 15%
Interest Coverage 4.11
Cash Conversion 81.88%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.9%
ROIC/WACC0.95
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.09%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.32%
Revenue Next 2Y-3.05%
Revenue Next 3Y-2.44%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year51.05%
EBIT Next 3Y13.12%
EBIT Next 5Y8.67%
FCF growth 1Y240.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.65%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status of ICADE (ICAD.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to ICADE (ICAD.PA). This can be considered as Undervalued.


How profitable is ICADE (ICAD.PA) stock?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for ICAD stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.05 and the Price/Book (PB) ratio is 0.41.


What is the earnings growth outlook for ICADE?

The Earnings per Share (EPS) of ICADE (ICAD.PA) is expected to grow by 10.09% in the next year.